Cargando…

The relationship between plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis

Detalles Bibliográficos
Autores principales:	Yarmolinsky, James, Barbieri, Natália Bordin, Weinmann, Tobias, Duncan, Bruce B, Schmidt, Maria Inês
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653508/ http://dx.doi.org/10.1186/1758-5996-7-S1-A119

Ejemplares similares

Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies
por: Yarmolinsky, James, et al.
Publicado: (2016)

Close relationship of PAI-1 (plasminogen activator inhibitor-1) with multiple organ dysfunction syndrome and abnormal glucose metabolism investigated by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (1998)

Regional release of tissue-type plasminogen activator in sepsis: effects of volume resuscitation
por: Seeman-Lodding, H, et al.
Publicado: (2001)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Predictive role of plasminogen-activator-inhibitor-1 (PAI-1) in non-ST-segment elevation acute coronary syndrome
por: Sinkovic, A, et al.
Publicado: (2002)

Timing and type of alcohol consumption and the metabolic syndrome: ELSA-Brasil
por: Vieira, Bruna Angelo, et al.
Publicado: (2015)

tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood glucose control by artificial pancreas
por: Hoshino, M, et al.
Publicado: (1999)

Relationship of polymorphisms in microRNAs -124 e -126 with diabetic retinopathy in patients with type 2 diabetes
por: Polina, Evelise Regina, et al.
Publicado: (2015)

Massive underreporting of type II Diabetes in emergency department admissions
por: Gustafsson, Josefin, et al.
Publicado: (2013)

Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

Prevalence of diabetes mellitus in Brazil: a systematic review with meta-analysis
por: Cureau, Felipe Vogt, et al.
Publicado: (2015)

Relationship between insulin administration and substrates oxidation during continuous aerobic exercise in adolescents with type 1 diabetes mellitus
por: Decimo, Juliana Pereira, et al.
Publicado: (2015)

Comparative effects of a dipeptidyl peptidase-4 inhibitor and of NPH insulin on peripheral nerve conduction of patients with type 2 diabetes
por: da Silva, Giordana Maluf, et al.
Publicado: (2015)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
por: Jasmiad, Nurbadriah binti, et al.
Publicado: (2022)

Evaluation of lipid homeostasis in the late gestational period of rats exposed to dexamethasone
por: Motta, Katia, et al.
Publicado: (2015)

Translational research in type 2 diabetes
por: Ning, Guang
Publicado: (2012)

Relationship between the education level and dermatological lesions in feet of diabetic patients
por: de Lima, Imaikon Gomes, et al.
Publicado: (2015)

Efficacy of SGLT2 inhibitors in glycemic control, weight loss and blood pressure reduction: a systematic review and meta-analysis
por: Pinto, Lana Catani, et al.
Publicado: (2015)

Peripheral edema in a diabetic patient on ACE inhibitor: differential diagnosis
por: Hébert, Jacques, et al.
Publicado: (2012)

Problem areas in diabetes and glicemic control in type 1 diabetes in a public diabetes center
por: Lourenço, Paula Lamego, et al.
Publicado: (2015)

Psychosocial risks for diabetic control of preadolescents and adolescents with Diabetes Mellitus Type I
por: Stankovic, Miodrag, et al.
Publicado: (2010)

Childhood chronic urticaria and type 1 diabetes
por: Mazzetti, A, et al.
Publicado: (2011)

Interdisciplinary education group in type 1 diabetes
por: Lopes, Lucia Hitomi Kamata, et al.
Publicado: (2015)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Integrase inhibitors effective against human T-cell leukemia virus type 1
por: Seegulam, Muhammad E, et al.
Publicado: (2011)

Illiteracy and diabetes: educational program for people with type 2 diabetes in the public health system
por: de Oliveira, Sheila Mara Silva, et al.
Publicado: (2015)

Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial
por: Barbieri, Douglas Eugenio, et al.
Publicado: (2015)

The impact of nutritional counseling in the healthy diet score in type 1 and type 2 diabetes
por: Fóscolo, Rodrigo Bastos, et al.
Publicado: (2015)

Diabetes education improves eating habits and quality of life in type 1 diabetes in carbohydrate counting
por: Guimarães, Débora Bohnen, et al.
Publicado: (2015)

Pharmacogenomics in type 2 diabetes management: towards personalized medicine
por: Hu, Cheng
Publicado: (2012)

Type 2 diabetes education programmes – focusing on patients’ perceptions
por: Hastings, Julie, et al.
Publicado: (2015)

Reuse of disposable syringes and needles in patients with type 2 diabetes
por: Guterres, Cátia Moreira, et al.
Publicado: (2015)

Quality of life related to health in adolescents with type 1 diabetes
por: Marini, Ana Clara Barreto, et al.
Publicado: (2015)

Glycemic control affecting the autonomic modulation in type 2 diabetes
por: Bassi, Daniela, et al.
Publicado: (2015)

Adiposity markers and insulin resistance in type 1 diabetes patients
por: Marques, Camila Lemos, et al.
Publicado: (2015)

Comparing the level of physical activity in women with type 2 diabetes
por: Alves, Caroline Hellen Rampazzo, et al.
Publicado: (2015)

Circulating microRNAs as biomarkers for type 1 diabetes mellitus
por: Assmann, Tais Silveira, et al.
Publicado: (2015)

Determinants of glycemic and blood pressure control in type 2 diabetes patients: 606 outpatients diabetes cohort
por: Coelli, Sabrina, et al.
Publicado: (2015)

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2012)

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tjf0v2u0v8t1rh4lk8t3noefoq